Common Stock, Shares, Outstanding of Cogent Biosciences, Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cogent Biosciences, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Cogent Biosciences, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 160,980,024, a 46% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Cogent Biosciences, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 160,980,024 +50,518,295 +46% 31 Dec 2025 10-K 17 Feb 2026 2025 FY
Q3 2025 139,827,662 +29,369,413 +27% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 113,928,492 +4,585,268 +4.2% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 113,856,454 +18,243,058 +19% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 110,461,729 +24,337,480 +28% 31 Dec 2024 10-K 17 Feb 2026 2025 FY
Q3 2024 110,458,249 +24,334,000 +28% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 109,343,224 +24,009,059 +28% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 95,613,396 +24,666,606 +35% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 86,124,249 +16,230,815 +23% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 86,124,249 +16,266,277 +23% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 85,334,165 +19,626,451 +30% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 70,946,790 +25,127,524 +55% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 69,893,434 +26,087,512 +60% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 69,857,972 +30,006,950 +75% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 65,707,714 +25,876,947 +65% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 45,819,266 +8,624,999 +23% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 43,805,922 +11,458,017 +35% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 39,851,022 +29,173,737 +273% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 39,830,767 +8,668,826 +28% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 37,194,267 +6,372,375 +21% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 32,347,905 +24,682,142 +322% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 10,677,285 -19,985,769 -65% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 31,161,941 +501,387 +1.6% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 30,821,892 +703,070 +2.3% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 7,665,763 -22,392,207 -74% 31 Dec 2019 10-K 16 Mar 2021 2020 FY
Q3 2019 30,663,054 +738,465 +2.5% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 30,660,554 +793,306 +2.7% 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 30,118,822 +19,910,764 +195% 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q4 2018 30,057,970 +19,856,280 +195% 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q3 2018 29,924,589 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 29,867,248 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 10,208,058 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 10,201,690 31 Dec 2017 10-K 28 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.